1. Introduction {#sec1-medicines-03-00003}
===============

The non-polar extracts of aromatic medicinal plant species are mainly composed of essential oils (EOs) and other complex mixture of compounds, mainly monoterpenes, sesqiuterpenes, long chain aliphatics, and their oxygenated derivatives (alcohols, aldehydes, esters, ethers, ketones, phenols, and oxides). These constituents may be obtained from different plant materials such as flowers, bark, wood, twigs, leaves, and roots \[[@B1-medicines-03-00003]\].

The genus Albizia is comprised of about 150 species widely distributed in tropics, with great diversity in Africa and Central South America \[[@B2-medicines-03-00003]\]. *Albizia adianthifolia* (Schumach), (Family: Fabaceae, Mimosoideae), is a large deciduous tree, trivially known as flat crown Albizia, that grows and habitats well in both dry woodland and sandy soils. It is valued as a shade tree in cocoa and coffee plantations in Sierra Leone as well as for soil conservation. Amongst other economic important uses of this species is its utilization in light constructions (e.g., rafters, posts) and carvings (e.g., spoons, clubs). Extensive literature survey revealed that various parts of *A. adianthifolia* have been used for a number of folkloric applications to treat such diseases such as skin and respiratory tract infections, headaches, sinusitis, and malaria, as well as use as analgesic, purgative, anti-inflammatory, and as a psychotic principle \[[@B3-medicines-03-00003],[@B4-medicines-03-00003]\].

*Pterocarpus* genus is comprised of 100 species amongst which is included *Pterocarpus angolensis* (DC), (Family: Fabaceae, Papillionoideae)*. P. angolensis* is mainly found in the tropical regions of Africa as well as the Neotropical regions and Indomalaya \[[@B5-medicines-03-00003]\]. It is a deciduous large tree, 18--19 m tall with a dark brown bark and a high wide-crowned canopy of shiny compound leaves. The leaves, which are alternate, deep green and imparipinnate, appear at the time of flowering or shortly afterwards. The pod has a diameter of about 2--3 cm, is surrounded by a circular wing which is 8--12 cm in diameter, reminiscent of a brown fried egg, and contains a single seed. This characteristic brown papery and spiky seed pod stays on long after the leaves have fallen from the tree. *P. angolensis* grows well on deep sandy soils or well drained rocky slopes and on open woodland areas. Owing to its excellent general properties the timber from *P. angolensis* has many applications in the building and furniture industries. *P. angolensis* is a woody tree that is revered because of its great natural durability \[[@B6-medicines-03-00003]\]. The sticky deep red/maroon colored sap is used as dye for fabric. In folk medicine, *P. angolensis* is mainly used for gastro-intestinal, urino-genital, fertility problems, respiratory conditions, and skin afflictions \[[@B7-medicines-03-00003]\]. The traditional use of extracts from *A. adianthifolia* and *P. angolensis* seem to suggest, among others, efficacy against free radical induced and microbial infections.

There are literature reports on the composition of non-polar constituents from both Albizia and Pterocarpus generra. For example, the GC-MS analysis of the ethanolic and *n*-hexane extracts of the stem bark of *A. chevalieri* \[[@B8-medicines-03-00003]\] and the ethanolic extracts of the stem bark and heartwood of *P. marsupium* along with their identified (antimicrobial, antioxidant, preservative, lubricant, flavor *etc.*) activities were reported \[[@B9-medicines-03-00003]\]. To the best of our knowledge, no study concerning the non-polar extracts of the heartwood and stem bark of either *A. adianthifolia* or *P. angolensis* has been reported.

Due to the diversity of folkloric uses of *A. adianthifolia* and *P. angolensis* against a number of diseases, we considered it worthwhile to determine the non-polar constituents of these two plant species. This was done by GC-MS analysis of the non-polar *n*-hexane and chloroform extracts and identification of the components was achieved by comparison of the acquired spectra with the existing NIST library. We were able to isolate other constituents using conventional column chromatography whose structures were elucidated using NMR spectroscopy. The presence of some of these constituents was later confirmed by GC-MS analysis. The GC-MS analysis of the non-polar constituents, not surprisingly, revealed that some components were in fairly high concentrations (major components) while other were only present in trace amounts \[[@B10-medicines-03-00003]\].

2. Materials and Methods {#sec2-medicines-03-00003}
========================

Analytical reagents (AR) and general purpose reagents (GPR) solvents were used. The GPR solvents were distilled using simple distillation before use.

2.1. Collection of Plant Materials {#sec2dot1-medicines-03-00003}
----------------------------------

The heartwood of *A. adianthifolia* was collected from Sokoto, north-western Nigeria in January, 2011. The plant species was identified by Mal. Auwal Muhammad, Botany Unit, Biological Sciences, Usmanu Danfodiyo University Sokoto, Nigeria and a voucher specimen, UDUH/ANS/0029, was deposited in the University Herbarium. The stem bark of *P. angolensis* was collected from Kasane in the northern region of Botswana in June 2012 and was identified at the Botany unit of Biological Sciences, University of Botswana where a voucher specimen was also deposited. The samples were air dried under shade, pulverized into course powder using Thomas Wiley Model 4 and stored in air tight containers until use.

2.2. Extraction Method {#sec2dot2-medicines-03-00003}
----------------------

The heartwood of *A. adianthifolia* (657.51 g) was successively and exhaustively extracted with *n*-hexane, chloroform, methanol, and 10% methanol (aq). The *n*-hexane and chloroform extracts, upon concentration under reduced pressure using a rotavapor (Buchi, Flawil, Switzerland) (\<40 °C), yielded respectively orange-yellow (0.95 g) and yellowish-green (9.16 g) crude extracts. Following a similar extraction protocol the stem bark of *P. angolensis* (2.21 kg) yielded *n*-hexane (yellow paste; 51.45 g), and chloroform (reddish-brown paste; 11.6 g) crude extracts.

A small portion of the *n*-hexane crude extract from each species was dissolved in chloroform and subjected to GC-MS analysis. The main crude chloroform extract from each of the species was separately adsorbed on coarse silica gel (0.2--0.5 mm) ratio (1:1), and allowed to dry before packing or loading onto a column with fine silica gel 60 (0.040--0.063 mm). The extracts were separately eluted under vacuum liquid chromatography (VLC) using *n*-hexane-chloroform-methanol in increasing (10%) polarity until 100% methanol.

The crude chloroform extract of the heartwood *of A. adiantifolia* yielded 52 fractions (50 mL each). These fractions were pooled based on the analytical TLC profiling (using acetone/*n*-hexane, 3:7) to give fractions 1--9 which were encoded ''**A**''. Fraction ''**A**'' was then subjected to GC-MS analysis. Using the same procedure, the crude chloroform extract of the stem bark of *P. angolensis* yielded 79 fractions. These were combined to give sub-fractions **A**--H. Sub-fraction F was adsorbed on coarse silica gel and subjected to column chromatography using different solvent systems (*n*-hexane/chloroform/acetone) in increasing (10%) polarity to yield 19 sub-fractions. These were combined which further yielded eight sub-fractions encoded F1--F8. From sub-fraction F3, a white crystalline solid (15.5 mg) was obtained which was identified by NMR spectroscopy as stigmasterol. The presence of stimasterol in the crude chloroform extract was confirmed by GC-MS analysis.

2.3. Procedure for GC-MS Analysis {#sec2dot3-medicines-03-00003}
---------------------------------

The *n-*hexane extracts obtained from the heartwood and stem bark of *A. adianthifolia* and *P. angolensis* respectively were analyzed separately by GC-MS using a HP-5MS capillary column (30 m × 250 μm, i.d., 0.25 μm film thickness) in an Agilent 6890N gas chromatograph (Agilent Technologies, Palo Alto, CA, USA) coupled to a water GCT Premier mass spectrometer (Waters Corporation, Milford, MA, USA). The carrier gas was helium with a constant flow rate of 3 mL/min. The oven temperature was initially kept at 100 °C for 4 min then ramped at 10 °C/min to 240 °C. The temperature was gradually increased from 8 °C/min to 300 °C and held isothermally for 10 min. An amount of 1.0 μL of the sample (100 ppm in chloroform) solutions was injected in the splitless mode. Mass spectra were obtained by EI at 70 eV over the scan range *m*/*z* 50−800. The compounds were identified by comparison of their mass spectra with those of the NIST 05 L mass spectral library. The spectral match factor limit was set at 700 and any components with match factor less than 700 were not considered \[[@B11-medicines-03-00003]\].

2.4. Procedure for Antimicrobial Activity {#sec2dot4-medicines-03-00003}
-----------------------------------------

The antimicrobial activities of the extracts were evaluated using the modified agar overlay method \[[@B12-medicines-03-00003],[@B13-medicines-03-00003],[@B14-medicines-03-00003]\]. The nutrient broth was prepared by dissolving (13 g/L) in distilled water and heating on a hotplate equipped with magnetic stirrer until a homogenous mixture was obtained. Then 50 mL of the nutrient broth was transferred into 250 mL (×5 for each organism) Erlenmeyer flasks and stoppered with cotton wool and aluminum foil. The nutrient agar was prepared by dissolving (28 g/L) in distilled water in a similar manner as the nutrient broth. The two (nutrient broth and nutrient agar) were separately autoclaved for 15 min at 121 °C. The nutrient broth was cooled in a Biohazard cabinet while the nutrient agar was kept in an oven set at 45 °C until ready to use.

Suspensions (10 mL) of the reconstituted pathogens were separately introduced into labeled 250 mL (×5) Erlenmeyer flasks containing 100 mL warm nutrient agar. Using sterile graduated pipettes, the pathogens were administered and spread as evenly as possible onto the pre-coated silica gel TLC plates already loaded with the different compounds in various loadings *i.e.*, 100, 50, 10, 5, 1 (μg). The nutrient agar containing the pathogens administered was allowed to solidify before being incubated for 24 h at 37 °C and 28 °C for the bacterial and fungal strains respectively. The zones of inhibitions (in "mm" after 24 h) were measured after staining of the plates with methylthiazolyltetrazolium chloride (MTT---2 mg/mL). Chloramphenicol and miconazole were used as standards for the bacterial and fungal strains respectively. The entire microbial assay was conducted under strict aseptic conditions.

3. Results and Discussions {#sec3-medicines-03-00003}
==========================

3.1. GC-MS Analysis {#sec3dot1-medicines-03-00003}
-------------------

GC-MS analysis of the volatile chemical compositions of *A. adianthifolia* (heartwood) and *P. angolensis* (stem bark) from the *n-*hexane and chloroform extracts were highly complex containing glycosides, ketone, saturated and unsaturated fatty acids, alcohols, and sterols ([Table 1](#medicines-03-00003-t001){ref-type="table"} and [Table 2](#medicines-03-00003-t002){ref-type="table"}). These constituents were presented according to the extracts from which they were identified in the next sections of this report.

### 3.1.1. GC-MS Analysis of *A. adianthifolia* {#sec3dot1dot1-medicines-03-00003}

Seven constituents were predominantly found in the heartwood of *A. adianthifolia* ([Figure 1](#medicines-03-00003-f001){ref-type="fig"}, see also [Figures S1 and S2](#app1-medicines-03-00003){ref-type="app"}). The peak areas (or percentage compositions of the metabolites shown in the brackets) are relative to other constituents within the crude extracts and whose match factors were greater than 700. Five of these were from the *n*-hexane extract. They include *n*-hexadecanoic acid **1** (34.85%), stigmasterol **4** (28.64%), oleic acid **2** (6.28%), 24S 5α-stigmast-7-en-3β-ol **5** (4.37%), chondrillasterol **3** (18.23%). While the remaining two---*i.e.*, 9,12-octadecadienoic acid (Z,Z)-, methyl ester **6** (17.58%) and *trans*-13-octadecenoic acid, methyl ester **7** (37.23%)---were from the chloroform extract ([Table 1](#medicines-03-00003-t001){ref-type="table"}). Most of these constituents have been found to show interesting biological activity against certain illnesses and/or pathogens. For instance, the anti-inflammatory \[[@B15-medicines-03-00003]\], antioxidant, hypocholesterolemic \[[@B16-medicines-03-00003]\], antibacterial \[[@B17-medicines-03-00003]\], activities reported for *n*-hexadecanoic acid **1**, may suggest the rationale for the traditional use of the species.

medicines-03-00003-t001_Table 1

###### 

Phyto-constituents identified from heartwood of *A. adianthifolia* by GC-MS analysis.

  Species                                        Compd. Name/No                                     Mol. Formula     Mol. Wt.   NIST Match Factor: Forward, Reverse   RT (min)   Peak Area (%)                                                                                                                                                                                                             Reported Bioactivity
  ---------------------------------------------- -------------------------------------------------- ---------------- ---------- ------------------------------------- ---------- ------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------- -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  *A. adianthifolia* (*n*-hexane extract)        *n*-hexadecanoic acid 1                            C~16~H~32~O~2~   256        858, 880                              16.65      34.85                                                                                                                                                                                                                     Anti-inflammatory \[[@B15-medicines-03-00003]\], Antioxidant, hypocholesterolemic nematicide, pesticide, anti androgenic flavor, hemolytic, 5-Alpha reductase inhibitor \[[@B16-medicines-03-00003]\], potent mosquito larvicide \[[@B17-medicines-03-00003]\].
  oleic acid 2                                   C~18~H~34~O~2~                                     282              754, 892   18.27                                 6.28       Antibacterial \[[@B18-medicines-03-00003]\].                                                                                                                                                                              
  chondrillasterol 3                             C~29~H~48~O                                        412              805, 935   29.29                                 18.23      Cytotoxicity \[[@B19-medicines-03-00003]\].                                                                                                                                                                               
  stigmasterol 4                                 C~29~H~48~O                                        412              818, 830   29.30                                 28.64      Thyroid inhibitory, antiperoxidative and hypoglycemic effects \[[@B20-medicines-03-00003]\].                                                                                                                              
  24S, 5α stigmast-7-en-3β-ol 5                  C~29~H~50~O                                        414              809, 930   30.02                                 4.37       Antimutagenic \[[@B21-medicines-03-00003]\].                                                                                                                                                                              
  Total = 92.37                                                                                                                                                                                                                                                                                                                                                                                            
  *A. adianthifolia* (chloroform extract)        9,12-octadecadienoic acid (Z,Z)-, methyl ester 6   C~19~H~34~O~2~   294        750, 895                              17.76      17.58                                                                                                                                                                                                                     Anti-cancer \[[@B22-medicines-03-00003]\].
  *trans*-13-octadecanoic acid, methyl ester 7   C~19~H~36~O~2~                                     296              857, 907   17.81                                 37.23      Anti-inflammatory, antiandrogenic, cancer preventive, dermatitigenic, irritant, antileukotriene---D4, hypocholesterolemic, 5-alpha reductase inhibitor, anemiagenic, insectifuge, flavor \[[@B23-medicines-03-00003]\].   
  Total = 54.81                                                                                                                                                                                                                                                                                                                                                                                            

### 3.1.2. GC-MS Analysis of *P. angolensis* {#sec3dot1dot2-medicines-03-00003}

Ten volatile phytoconstituents were found to be the most abundant in the *n-*hexane extract of the stem bark of *P. angolensis* ([Figure 2](#medicines-03-00003-f002){ref-type="fig"}). These constituents and their calculated percentage peak area compositions include tetratriacontane **11** (31.67%), *n*-hexadecanoic acid **1** (10.29%), 7-dehydrodiosgenin **12** (9.58%), stigmasta-3,5-dien-7-one **14** (7.13%), lupeol **13** (6.54%), octadecanoic acid **10** (5.89%), friedelan-3-one **15** (2.56%), hexadecanoic acid, methyl ester **9** (1.84%), and tetradecanoic acid **8** (1.84%). While from the chloroform extract, 1-octacosanol **16** (9.87%), was isolated after several chromatographic separation techniques, elucidated using NMR spectroscopic data and confirmed/identified via GC-MS analysis ([Table 1](#medicines-03-00003-t001){ref-type="table"} and [Table 2](#medicines-03-00003-t002){ref-type="table"}, see also [Figures S3 and S4](#app1-medicines-03-00003){ref-type="app"}).

medicines-03-00003-t002_Table 2

###### 

Phytocomponents identified from the stem bark of *P. angolensis* by GC-MS analysis.

  Species                                 Compd. Name/No.            Mol. Formula     Mol. Wt.   NIST Match Factor: Forward, Reverse   RT (min)      Peak Area (%)                                                                                                                                    Reported Bioactivity
  --------------------------------------- -------------------------- ---------------- ---------- ------------------------------------- ------------- ------------------------------------------------------------------------------------------------------------------------------------------------ ------------------------------------------------------------------
  *P. angolensis* (*n*-hexane extract)    tetradecanoic acid **8**   C~14~H~28~O~2~   228        835, 902                              14.52         1.84                                                                                                                                             Larvicidal and repellent activity \[[@B24-medicines-03-00003]\].
  hexadecanoic acid, methyl ester **9**   C~17~H~34~O~2~             270              879, 903   16.15                                 1.84          Antibacterial and antifungal \[[@B25-medicines-03-00003]\]                                                                                       
  *n*-hexadecanoic acid **1**             C~16~H~32~O~2~             256              864, 879   16.70                                 10.29         See above                                                                                                                                        
  octadecanoic acid **10**                C~18~H~36~O~2~             284              780, 825   18.48                                 5.89          Antimicrobial activity \[[@B17-medicines-03-00003]\].                                                                                            
  tetratriacontane **11**                 C~34~H~70~                 478              759, 874   24.79                                 31.67         Antibacterial and antifungal \[[@B26-medicines-03-00003]\]                                                                                       
  7-dehydrodiosgenin **12**               C~27~H~40~O~3~             412              721, 736   26.59                                 9.58          Antibacterial, antifungal,, antioxidant, cytotoxic \[[@B27-medicines-03-00003],[@B28-medicines-03-00003]\]                                       
  lupeol **13**                           C~30~H~50~O                426              832, 897   30.48                                 6.54          Anti-inflammatory activity \[[@B29-medicines-03-00003]\], Anti-cancer \[[@B30-medicines-03-00003]\].                                             
  stigmasta-3,5-dien-7-one **14**         C~29~H~46~O                410              817, 864   30.66                                 7.13          Free radical scavenging? Anti-diabetic, anticancer? \[[@B31-medicines-03-00003],[@B32-medicines-03-00003]\]                                      
  friedelan-3-one **15**                  C~30~H~50~O                426              882, 903   32.91                                 2.56          Antibacterial, antifungal, anti-inflammatory, analgesic, antipyretic, antihypertensive \[[@B33-medicines-03-00003],[@B34-medicines-03-00003]\]   
  Total = 77.34                                                                                                                                                                                                                                                                                       
  *P. angolensis* (chloroform extract)    \* 1-octacosanol **16**    C~28~H~58~O      410        837, 918 813, 891                     26.44 28.61   37.73 62.27                                                                                                                                      Antioxidant \[[@B35-medicines-03-00003]\].
  Total = 100                                                                                                                                                                                                                                                                                         

\* Same compound but appeared at two different RT (min) showing two distinct peaks on the spectrum and with different % compositions.

The compound *n*-hexadecanoic acid **1** was found in both extracts from the different species. It may be inferred that both species have similarities in terms of their traditional applications and effectiveness against such illnesses as skin diseases and respiratory conditions and as anti-inflammatories and analgesics may be due to the presence of *n*-hexadecanoic acid **1**.

3.2. Structure Elucidation of Compound **16** {#sec3dot2-medicines-03-00003}
---------------------------------------------

The proton-decoupled ^13^C-NMR showed an envelope of carbons resonating at **δ**~C~ 29.7--29.4 in addition to six other carbon signals which from the DEPT 135 spectrum gave one methyl at δ~C~ 14.1, the remaining five were methylene carbons which resonated between δ~C~ 32.9--22.7. However, except for the methyl carbon at δ~C~ 14.1, and the carbon that resonated at δ~C~ 63.1 which is characteristic of an oxygenated aliphatic methylene carbon, the rest were typical sp^3^ aliphatic methylene carbons. From the ^1^H-NMR, a two proton broad singlet at δ~H~ 3.69 (characteristic of an oxygenated aliphatic environment), another triplet of three protons appearing up field δ~H~ 0.93 (typical of a terminal aliphatic methyl) were observed. Three apparent singlets were observed at δ~H~ 2.22, δ~H~ 1.63, and δ~H~ 1.30 due possibly to insufficient resolution on a 300 MHz NMR. These apparent singlet signals (which should have been quintets or at worst multiplets) were characteristic of sp^3^ aliphatic methylene protons ([Table 3](#medicines-03-00003-t003){ref-type="table"}, see also [Figures S5 and S6](#app1-medicines-03-00003){ref-type="app"}). These data are consistent with a long aliphatic chain attached to a hydroxyl group. Further confirmation was obtained from the GC-MS library data match. Thus, compound **16** was identified as 1-octacosanol.

medicines-03-00003-t003_Table 3

###### 

^1^H (300 MHz) and ^13^C (75 MHz) NMR spectra of 16 in CDCl~3~.

  Position   δ~H~(ppm)               δ~C~ (ppm)
  ---------- ----------------------- ------------
  1          3.69, 2H, *br s* *\**   63.1
  2          2.22, 2H, *s* *\**      32.9
  3          1.63, 2H, *s* *\**      32.0
  4--27      1.35--1.30, 49H, *s*    29.7--22.7
  28         0.93, 3H, *t,* (6.6)    14.1

*\** = apparent singlet.

![Structures of non-polar constituents identified from *A. adianthifolia* using GC-MS analysis.](medicines-03-00003-g001){#medicines-03-00003-f001}

![Structures of non-polar constituents identified from *P. angolensis* using GC-MS analysis.](medicines-03-00003-g002){#medicines-03-00003-f002}

3.3. Result for the Preliminary Antimicrobial Assay {#sec3dot3-medicines-03-00003}
---------------------------------------------------

The bioactivity reported (from other species) for these metabolites identified from the crude extracts of *A. adianthifolia* and *P. angolensis* against a variety of diseases ([Table 1](#medicines-03-00003-t001){ref-type="table"} and [Table 2](#medicines-03-00003-t002){ref-type="table"}), necessitated the preliminary antimicrobial assay. The preliminary antimicrobial assay of the extracts showed different responses to the test organisms with best activity observed for both *n*-hexane and chloroform extracts of *A. adianthifolia* against *E. coli* with MIQ of 1 μg ([Table 4](#medicines-03-00003-t004){ref-type="table"}). The *P. angolensis* stem bark extracts were observed to show poor-to-no activity against the test pathogens except for the weak response of the chloroform extract against *B. subtilis* with MIQ of 50 μg. The preliminary antimicrobial potency of these species is generally characterized by weak to poor activity as none of the extracts demonstrated activity comparable to the standards used (*i.e.*, chloramphenicol and miconalzole).

medicines-03-00003-t004_Table 4

###### 

Preliminary antimicrobial activity of the different extracts.

  Species              Part        Extract      Microbial Strains and MIQ (μg)                          
  -------------------- ----------- ------------ -------------------------------- ------- ------ ------- -------
  *A. adianthifolia*   heartwood   *n*-hexane   1                                50      50     50      \>100
  *A. adianthifolia*   heartwood   Chloroform   1                                50      50     50      \>100
  *P. angolensis*      stem bark   *n*-hexane   \>100                            \>100   100    \>100   100
  *P. angolensis*      stem bark   Chloroform   \>100                            \>100   50     \>100   100
  Chloramphenicol                               0.50                             10      0.25   0.50    N.A
  Miconazole                                    N.A                              N.A     N.A    N.A     0.25

Not active at a loading \>100 μg; N.A = not applicable. MIQ = minimum inhibition quantities.

4. Conclusions {#sec4-medicines-03-00003}
==============

The GC-MS analysis showed the presence of sixteen phytochemical constituents from the non-polar and medium polar extracts of the heartwood and stem bark of the *A. adianthifolia* and *P.* *angolensis* respectively. Although the preliminary antimicrobial assay did not convincingly corroborate with the acclaimed folkloric uses with only moderate to weak activity exhibited by the pathogens tested, it could be considered that the efficacy of these species in certain illnesses could be associated with the presence of similar phyto-constituents (*i.e.*, *n*-hexadecanoic acid 1). Detailed phytochemical investigation should be carried out on the polar extracts to identify other constituents that may have led to the popular use of these species in folklore medicine.
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###### 
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